Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT04876274 Completed - Type 2 Diabetes Clinical Trials

Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic

Start date: July 14, 2020
Phase: N/A
Study type: Interventional

The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals. This study also evaluated its effectiveness on improving glycemic control, attitude towards diabetes, knowledge about diabetes and self-care for type 2 diabetes patients in Taiwan. The followings were the hypotheses of the study: 1. Compared to the control group, intervention group receiving "Line" based video education has a greater improvement on glycosylated hemoglobin (A1C). 2. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on attitude towards diabetes. 3. Compared to the control group, intervention group receiving "Line" based video education has a better understanding on diabetic knowledge. 4. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on self-care activity.

NCT ID: NCT04874415 Recruiting - Type 2 Diabetes Clinical Trials

Behavioral Economics for Activity Motivation in Adolescents (BEAM)

Start date: November 16, 2021
Phase: N/A
Study type: Interventional

There is an urgent need to engineer targeted physical activity interventions that are effective and scalable for obese adolescents and young adults (AYA) with type 2 diabetes (T2D), who often have very low levels of physical activity. The BEAM Trial is a proposed mobile health (mHealth) intervention that uses behavioral economic-informed financial incentives and text messaging to promote physical activity in AYA with T2D and prediabetes.

NCT ID: NCT04869098 Recruiting - Type 2 Diabetes Clinical Trials

Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)

PROPENSITy
Start date: April 27, 2021
Phase: N/A
Study type: Interventional

This study will compare the effects of a whey protein supplement or a placebo consumed before the evening meal on health outcomes in night shift workers.

NCT ID: NCT04867785 Completed - Type 2 Diabetes Clinical Trials

A Study of LY3437943 in Participants With Type 2 Diabetes

Start date: May 13, 2021
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of LY3437943 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin. This study will last about 43 weeks.

NCT ID: NCT04864977 Withdrawn - Type 2 Diabetes Clinical Trials

A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

Start date: August 16, 2021
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to evaluate a novel approach for insulin glargine (LY2963016) titration for insulin-naïve adults with type 2 diabetes (T2D) The study will last about 6 months.

NCT ID: NCT04861324 Completed - Type 2 Diabetes Clinical Trials

Effects of a Lifestyle Intervention on Gestational Diabetes Management

Start date: April 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of nutrition education focusing on colorful fruit and vegetable intake with after-meal physical activity guidance on glycemic control and complications in women with gestational diabetes and pre-gestational diabetes.

NCT ID: NCT04854330 Not yet recruiting - Type 2 Diabetes Clinical Trials

Ketone Esters in T2DM

Start date: April 26, 2021
Phase: N/A
Study type: Interventional

Type 2 diabetes mellitus (T2DM) reduces the ability of the body to use sugar as a fuel. As an alternative people with T2DM can use fat from the blood stream instead. Fat is a good store of energy, however, the body requires about 20% more oxygen to produce energy from fat compared to sugar. People with T2DM often have heart disease as well. This can lead to limited availability of oxygen in the heart muscle, which increases the workload of the heart and will impact on the ability to perform everyday tasks, such as walking up a flight of steps. Recently, it has been suggested that ketone esters (a sports drink that contains ketones) may be used as an alternative source of energy for people with diabetes as they are approximately 8% more efficient than fat. The investigators will assess whether these ketones can be used as a more efficient source of energy and improve how the heart works in people with T2DM. If successful, this is a relatively cheap treatment, which could be immediately implemented in people with T2DM to improve heart function and the ability to perform everyday tasks.

NCT ID: NCT04847999 Completed - Type 2 Diabetes Clinical Trials

Dark Chocolate and Glucose Levels in Diabetes

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

Diabetes is a growing concern in the world with an estimated 9.3% of adults, ages 20-79, with it in 2019, type 2 diabetes accounting for 90% of this total. A common recommendation for individuals with diabetes is to limit sugars and sweets as it may cause a high blood glucose response. As a result, chocolate is often avoided due to the sugar content; though, high-polyphenol chocolate may have a beneficial effect on hyperglycaemia and vascular function. The sugar-free chocolate from Ross Chocolates is formulated with a blend of inulin, erythritol, and stevia. These alternatives to sugar are not expected to cause a significant change in blood glucose levels following consumption. The main objective of this study is to verify glucose levels before and after consumption of Ross Chocolates' blend of sweeteners dark chocolate and conventional chocolate in people with diabetes.

NCT ID: NCT04847219 Completed - Type 2 Diabetes Clinical Trials

Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus

Start date: October 9, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the efficacy and safety of premixed insulin treatment in patients With type 2 diabetes mellitus using professional and personal Flash Glucose Mornitoring.

NCT ID: NCT04841096 Recruiting - Type 2 Diabetes Clinical Trials

Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure

Start date: March 21, 2023
Phase: Phase 3
Study type: Interventional

Phase IIIb, randomized, multicenter, double-blind, prospective study to evaluate the efficacy and safety of a daily fixed-dose combination of glimepiride / vildagliptin / metformin in patients with type 2 diabetes with a history of dual treatment failure and combined or individual oral antidiabetics with SGLT2 / Metformin, Biguanide / Sulfonylurea, Sulfonylurea / iDPP4 or Biguanide / iDPP4. To evaluate the changes in the percentage of HbA1c at 3 and 6 months with regard to their baseline measurement.